Navigation Links
ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference
Date:4/2/2009

RANCHO CORDOVA, Calif., April 2 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today that its devices will be the subject of several scientific abstracts to be presented at the International Stem Cell Therapy (ISCT) 2009 Annual Meeting in San Diego, May 3-6.

The abstracts will cover the efficacy of the Company's BioArchive(R) System, MarrowXpress(TM) (MXP(TM)) and Res-Q(TM) devices in the processing of stem cells from cord blood and bone marrow. Additional abstracts will address the impact of sterilization practices on stem cell processing, and findings regarding the collection of equine stem cells. The Company will also be demonstrating its products at booth #200.

"We are delighted to have the opportunity to contribute to this leading stem cell industry conference. We believe this forum provides us the opportunity for the industry to be aware of the value of our devices in the collection and storage of stem cells from cord blood and bone marrow, as well as our ability to bring innovation to the market through devices such as the MXP and Res-Q," said Matthew Plavan, Chief Executive Officer of ThermoGenesis.

The abstracts to be presented at the ISCT include:

  • Findings from a company study designed to evaluate the efficiency of stem cell recovery from bone marrow following processing with the MXP and cryopreservation with the BioArchive. This study was conducted prior to the commercial launch of the MXP in late 2008. The data demonstrated nearly one hundred percent stem cell recovery and that the MXP can be successfully used to volume reduce and harvest stem cells from human bone marrow in a functionally closed system.
  • Results from a company study usin
    '/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ThermoGenesis Says FDA Concurs with Plan for Previously Announced AXP(TM) Bagset Recall
2. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2009 Results on February 4, 2009
3. ThermoGenesis Presentation at Rodman & Renshaw Conference
4. ThermoGenesis Corp. to Announce First Quarter Fiscal 2009 Results on November 6, 2008
5. ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
6. ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent
7. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
8. ThermoGenesis Names Tiffany Olson to Board of Directors
9. ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM))
10. ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)
11. ThermoGenesis Names Dr. Mahendra Rao to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... August 22, 2014 Nerium International, ... is in the spotlight again. Nerium will showcase ... its NeriumFirmTM Body Contouring Cream to Hollywood’s elite ... Creations during the 66th Primetime Emmy® Awards. , ... extract, third-party clinical trials show that NeriumAD night ...
(Date:8/21/2014)... 21, 2014  BioSpecifics Technologies Corp. (NASDAQ: ... in class collagenase-based products marketed as XIAFLEX ® ... U.S. and XIAPEX ® in the EU, ... randomized, double-blind Phase 2a study of CCH for ... panniculopathy. The results showed that all three doses ...
(Date:8/21/2014)... DESY scientists has observed tiny quantum vortices in cold ... journal Science that the exotic vortices arrange ... is the first time that the quantum vortices, which ... is known as superfluid helium, have been detected in ... Andrey Vilesov of the University of Southern California, one ...
(Date:8/21/2014)... His Majesty Willem-Alexander, King of the Netherlands ... His Majesty Willem-Alexander, King of the Netherlands, has announced ... POET-DSM Advanced Biofuels’ Project LIBERTY cellulosic ethanol plant in ... will take part in the Grand Opening Ceremony to ... p.m. and tour the plant. POET-DSM is a joint ...
Breaking Biology Technology:Nerium International Joins Television’s Biggest Stars at Backstage Creations Giving Suite at the 66th Primetime Emmy Awards 2Nerium International Joins Television’s Biggest Stars at Backstage Creations Giving Suite at the 66th Primetime Emmy Awards 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 4BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 5Scientists observe quantum vortices in cold helium droplets 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 3
... Treatment Approved by the Fda For Hypotrichosis of,Eyelashes ... and Drug Administration (FDA) has approved LATISSE(TM),(bimatoprost ophthalmic ... the eyelashes. Eyelash hypotrichosis is another name for,having ... first and only,FDA-approved, science-based treatment to enhance eyelash ...
... WALTHAM, Mass., Dec. 26 Interleukin Genetics, Inc. (NYSE ... 2008 the Company received notice from the NYSE Alternext ... is not in compliance with certain conditions of the ... Company Guide. Specifically, the Exchange noted the Company,s failure ...
... Minimize Viral Transmission, Including Norovirus , A ... public health by minimizing the transmission of multiple ... providers. The researchers from the University of ... Raleigh report their findings in the August 2008 ...
Cached Biology Technology:MultiVu Video Feed: U.S Food and Drug Administration (Fda) Approves Latisse(TM) -- 2MultiVu Video Feed: U.S Food and Drug Administration (Fda) Approves Latisse(TM) -- 3Interleukin Genetics Receives Notification of Failure to Meet Continued Listing Standard Section 1003(a)(iii) 2Interleukin Genetics Receives Notification of Failure to Meet Continued Listing Standard Section 1003(a)(iii) 3Tips from the journals of the American Society for Microbiology 2Tips from the journals of the American Society for Microbiology 3Tips from the journals of the American Society for Microbiology 4
(Date:8/21/2014)... American singles found that during sex with a ... On average, men experience orgasm 85.1 percent of ... difference. For women, however, orgasm occurrence is less ... of the time during sex with a familiar ... sexual orientation, with lesbian women experiencing orgasm more ...
(Date:8/21/2014)... unknown process for harvesting energy and producing oxygen from ... University scientist has discovered. The discovery lays the foundation ... energy from the Sun, and understanding dense blooms like ... worldwide. A paper describing the discovery will be published ... journal Science on 21 August 2014. , ...
(Date:8/21/2014)... linked to dandruff, eczema and other itchy, flaky maladies ... global reachesincluding Hawaiian coral reefs and the extreme environments ... review in the scientific journal PLOS Pathogens ... of the genus Malassezia in light of ... around the world. , University of Hawai,i at Mānoa ...
Breaking Biology News(10 mins):Orgasm rates for single women less predictable than men's, vary by sexual orientation 2Orgasm rates for single women less predictable than men's, vary by sexual orientation 3Orgasm rates for single women less predictable than men's, vary by sexual orientation 4Hot-spring bacteria reveal ability to use far-red light for photosynthesis 2Hot-spring bacteria reveal ability to use far-red light for photosynthesis 3From dandruff to deep sea vents, an ecologically hyper-diverse fungus 2
... of Biological Sciences (AIBS) and the National Evolutionary ... and workshop for educators at the National Association ... The special symposium, which has become a ... classroom teachers with an opportunity to hear directly ...
... Research and Forestry Applications (CREAF), in the celebration of ... of international experts to discuss the environmental future of ... The work of both days is summarized in the ... Sustainability, which you will find bellow. Targeted to governments ...
... in age-related macular degeneration, the most common cause of ... today in the Lancet , adds to the ... (AMD), which the researchers believe should ultimately lead to ... people aged 80 years or older are affected by ...
Cached Biology News:Illuminating biology: An evolutionary perspective 2Illuminating biology: An evolutionary perspective 3Illuminating biology: An evolutionary perspective 4Barcelona Declaration 2008: Challenges and Pathways to Earth Sustainability 2Barcelona Declaration 2008: Challenges and Pathways to Earth Sustainability 3Barcelona Declaration 2008: Challenges and Pathways to Earth Sustainability 4Genetic finding implicates innate immune system in major cause of blindness 2
Large-capacity refrigerated incubator chamber holds up to 4 independently-operated shakers. Programmable heat, refrigeration, humidifcation are standard. Photosynthetic operation, optional....
Denhardt's powder mixture (for 50X stock solution)...
... for monitoring acetylcholinesterase (AChE) activity. This is ... 5 min), non-radioactive and easy to use ... natural substrate, acetylcholine. A series of coupled ... AChE into a change in luminescence. Inhibitors ...
Rabbit polyclonal to Vitronectin ( Abpromise for all tested applications). Antigen: Full length Vitronectin protein (Mouse). Entrez Gene ID: 7448 Swiss Protein ID: P04004...
Biology Products: